2021-008 Unified Plan for Allocation and Use of Opioid Settlement Proceeds RESOLUTION NO. 2021-008
A RESOLUTION OF THE CITY COMMISSION OF THE
CITY OF OCOEE, FLORIDA, RELATING TO A
UNIFIED PLAN FOR THE ALLOCATION AND USE OF
OPIOID SETTLEMENT PROCEEDS; AUTHORIZING
ACCEPTANCE OF THE FLORIDA MEMORANDUM OF
UNDERSTANDING AND FORMAL AGREEMENTS
IMPLEMENTING A UNIFIED PLAN; PROVIDING FOR
SEVERABILITY; AND PROVIDING AN EFFECTIVE
DATE.
WHEREAS, the City of Ocoee is a litigating public entity with claims pending in the
federal district court In re: National Prescription Opiate Litigation, MDL No. 2804 (N.D. Ohio);
and
WHEREAS,the attorneys representing the State of Florida and various local governments
involved in the litigation have proposed a unified plan for the allocation and use of prospective
settlement dollars from the multidistrict litigation; and
WHEREAS,the Florida Memorandum of Understanding("Florida Plan")sets forth a non-
binding general framework of a unified plan for the proposed allocation and use of opioid
settlement proceeds and it is anticipated that formal agreements implementing the Florida Plan
will be entered into at a future date; and
WHEREAS, participation in the Florida Plan by a large majority of Florida cities and
counties will materially increase the amount of funds to Florida and should improve Florida's
relative bargaining position during additional settlement negotiations, and
WHEREAS,the City Commission of the City of Ocoee has determined that participation
in the Florida Plan is in the best interest of the City and its residents and citizens.
NOW, THEREFORE, BE IT RESOLVED BY THE CITY COMMISSION OF THE
CITY OF OCOEE, FLORIDA:
1
4849-1970-5336,v. 1
SECTION 1. AUTHORITY. This Resolution is adopted pursuant to the provisions of
the City of Ocoee Home Rule Charter; Article VIII, Section 2 of the Florida Constitution; Section
166.041, Florida Statutes; and other applicable provisions of law.
SECTION 2. UNIFIED PLAN. That the City Commission of the City of Ocoee hereby
acknowledges its support of a unified plan for the allocation and use of opioid settlement proceeds
as generally described in the Florida Memorandum of Understanding, attached hereto as Exhibit
"A" (the "Memorandum of Understanding").
SECTION 3. EXECUTION. That the City Attorney is hereby authorized to execute the
Memorandum of Understanding in substantially the form contained in the attached Exhibit "A"
and any other formal agreements implementing a unified plan for the allocation and use of opioid
settlement proceeds that is not substantially inconsistent with the Memorandum of Understanding
and this Resolution.
SECTION 4. RECORDATION. That the Clerk be and hereby is instructed to record
this Resolution in the appropriate record book upon its adoption.
SECTION 5. SEVERABILITY. If any clause, section, or other part of this Resolution
shall be held by any court of competent jurisdiction to be unconstitutional or invalid, such
unconstitutional or invalid part shall be considered as eliminated and in no way affecting the
validity of other provisions of this Resolution.
SECTION 6. EFFECTIVE DATE. This Resolution shall take effect immediately upon
its passage and adoption.
2
4849-1970-5336,v. 1
PASSED AND ADOPTED this 77 day of bar , 2021.
APPROVED:
ATTEST: CITY OF OCOEE,FLORIDA
et !III...--
Me anie Sibbitt, MMC, City Clerk Rusty Johnson, 3fir
(SEAL)
FOR USE AND RELIANCE ONLY BY APPROVED BY THE OCOEE CITY
THE CITY OF OCOEE,FLORIDA; COMMISSION AT A MEETING HELD
APPROVED AS TO FORM AND ON,149ieryih,fri 7 ,2021,
LEGALITY THIS 7-Ai DAY OF UNDER AGENDA ITEM NO. o? .
j ,2021.
SHUFFIELD,LOWMAN&WILSON,P.A.
By: eve, t
City Attorne ( 1
3
4849-1970-5336,v. 1
PROPOSAL
MEMORANDUM OF UNDERSTANDING
Whereas, the people of the State of Florida and its communities have been harmed by
misfeasance, nonfeasance and malfeasance committed by certain entities within the
Pharmaceutical Supply Chain;
Whereas, the State of Florida, through its Attorney General, and certain Local
Governments, through their elected representatives and counsel, are separately engaged in
litigation seeking to hold Pharmaceutical Supply Chain Participants accountable for the damage
caused by their misfeasance, nonfeasance and malfeasance;
Whereas, the State of Florida and its Local Governments share a common desire to abate
and alleviate the impacts of that misfeasance, nonfeasance and malfeasance throughout the State
of Florida;
Whereas, it is the intent of the State of Florida and its Local Governments to use the
proceeds from Settlements with Pharmaceutical Supply Chain Participants to increase the amount
of funding presently spent on opioid and substance abuse education, treatment and other related
programs and services, such as those identified in Exhibits A and B, and to ensure that the funds
are expended in compliance with evolving evidence-based "best practices";
Whereas, the State of Florida and its Local Governments, subject to the completion of
formal documents that will effectuate the Parties' agreements, enter into this Memorandum of
Understanding("MOU")relating to the allocation and use of the proceeds of Settlements described
herein; and
Whereas, this MOU is a preliminary non-binding agreement between the Parties, is not ,
legally enforceable, and only provides a basis to draft formal documents which will effectuate the
Parties' agreements.
A. Definitions
As used in this MOU:
1. "Approved Purpose(s)" shall mean forward-looking strategies, programming and
services used to expand the availability of treatment for individuals impacted by substance use
disorders, to: (a) develop, promote, and provide evidence-based substance use prevention
strategies; (b) provide substance use avoidance and awareness education; (c) decrease the
oversupply of licit and illicit opioids;and(d)support recovery from addiction. Approved Purposes
shall include, but are not limited to, the opioid abatement strategies listed on Exhibits A and B
which are incorporated herein by reference.
2. "Local Governments" shall mean all counties, cities, towns and villages located
within the geographic boundaries of the State.
3. "Managing Entities" shall mean the corporations selected by and under contract
with the Florida Department of Children and Families or its successor ("DCF") to manage the
000003/01288125_1
daily operational delivery of behavioral health services through a coordinated system of care. The
singular"Managing Entity" shall refer to a singular of the Managing Entities.
4. "County" shall mean a political subdivision of the state established pursuant to s.
1,Art. VIII of the State Constitution.
5. "Municipalities" shall mean cities, towns, or villages of a County within the State
with a Population greater than 10,000 individuals and shall also include cities, towns or villages
within the State with a Population equal to or less than 10,000 individuals which filed a Complaint
in this litigation against Pharmaceutical Supply Chain Participants. The singular "Municipality"
shall refer to a singular of the Municipalities.
6. "Negotiating Committee" shall mean a three-member group comprised by
representatives of the following: (1)the State; and (2) two representatives of Local Governments
of which one representative will be from a Municipality and one shall be from a County
(collectively,"Members")within the State. The State shall be represented by the Attorney General
or her designee.
7. "Negotiation Class Metrics"shall mean those county and city settlement allocations
which come from the official website of the Negotiation Class of counties and cities certified on
September 11, 2019 by the U.S. District for the Northern District of Ohio in In re National
Prescription Opiate Litigation, MDL No. 2804 (N.D. Ohio). The website is located at
https://allocationmap.iclaimsonline.com.
8. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as
defined in this MOU.
9. "Opioid Related" shall have the same meaning and breadth as in the agreed Opioid
Abatement Strategies attached hereto as Exhibits A or B.
10. "Parties" shall mean the State and Local Governments. The singular word"Party"
shall mean either the State or Local Governments.
11. "PEC"shall mean the Plaintiffs'Executive Committee of the National Prescription
Opiate Multidistrict Litigation pending in the United States District Court for the Northern District
of Ohio.
12. "Pharmaceutical Supply Chain"shall mean the process and channels through which
Controlled Substances are manufactured, marketed,promoted, distributed or dispensed.
13. "Pharmaceutical Supply Chain Participant" shall mean any entity that engages in,
or has engaged in the manufacture, marketing,promotion, distribution or dispensing of an opioid
analgesic.
14. "Population" shall refer to published U.S. Census Bureau population estimates as
of July 1, 2019, released March 2020, and shall remain unchanged during the term of this MOU.
These estimates can currently be found at https://www.census.gov
15. "Qualified County" shall mean a charter or non-chartered county within the State
that: has a Population of at least 300,000 individuals and (a)has an opioid taskforce of which it is
a member or operates in connection with its municipalities or others on a local or regional basis;
(b)has an abatement plan that has been either adopted or is being utilized to respond to the opioid
epidemic; (c)is currently either providing or is contracting with others to provide substance abuse
prevention,recovery, and treatment services to its citizens; and(d)has or enters into an agreement
with a majority of Municipalities (Majority is more than 50% of the Municipalities' total
population)related to the expenditure of Opioid Funds.The Opioid Funds to be paid to a Qualified
County will only include Opioid Funds for Municipalities whose claims are released by the
Municipality or Opioid Funds for Municipalities whose claims are otherwise barred.
16. "SAMHSA" shall mean the U.S. Department of Health & Human Services,
Substance Abuse and Mental Health Services Administration.
17. "Settlement" shall mean the negotiated resolution of legal or equitable claims
against a Pharmaceutical Supply Chain Participant when that resolution has been jointly entered
into by the State and Local Governments or a settlement class as described in(B)(1)below.
18. "State" shall mean the State of Florida.
B. Terms
1. Only Abatement- Other than funds used for the Administrative Costs and Expense
Fund as hereinafter described in paragraph 6 and paragraph 9, respectively), all Opioid Funds shall
be utilized for Approved Purposes. To accomplish this purpose,the State will either file a new action
with Local Governments as Parties or add Local Governments to its existing action, sever settling
defendants, and seek entry of a consent order or other order binding both the State, Local
Governments, and Pharmaceutical Supply Chain Participant(s) ("Order"). The Order may be part
of a class action settlement or similar device. The Order shall provide for continuing jurisdiction of
a state court to address non-performance by any party under the Order. Any Local Government that
objects to or refuses to be included under the Order or entry of documents necessary to effectuate a
Settlement shall not be entitled to any Opioid Funds and its portion of Opioid Funds shall be
distributed to, and for the benefit of, the other Local Governments.
2. Avoid Claw Back and Recoupment-Both the State and Local Governments wish
to maximize any Settlement and Opioid Funds. In addition to committing to only using funds for
the Expense Funds,Administrative Costs and Approved Purposes,both Parties will agree to utilize
a percentage of funds for the core strategies highlighted in Exhibit A. Exhibit A contains the
programs and strategies prioritized by the U.S. Department of Justice and/or the U.S. Department
of Health &Human Services ("Core Strategies"). The State is trying to obtain the United States'
agreement to limit or reduce the United States' ability to recover or recoup monies from the State
and Local Government in exchange for prioritization of funds to certain projects. If no agreement
is reached with the United States, then there will be no requirement that a percentage be utilized
for Core Strategies.
3. Distribution Scheme -All Opioid Funds will initially go to the State, and then be
distributed according to the following distribution scheme. The Opioid Funds will be divided into
three funds after deducting costs of the Expense Fund detailed in paragraph 9 below:
(a) City/County Fund- The city/county fund will receive 15% of all Opioid Funds to
directly benefit all Counties and Municipalities. The amounts to be distributed to
each County and Municipality shall be determined by the Negotiation Class Metrics
or other metrics agreed upon,in writing,by a County and a Municipality. For Local
Governments that are not within the definition of County or Municipality, those
Local Governments may receive that government's share of the City/County Fund
under the Negotiation Class Metrics, if that government executes a release as part
of a Settlement. Any Local Government that is not within the definition of County
or Municipality and that does not execute a release as part of a Settlement shall
have its share of the City/County Fund go to the County in which it is located.
(b) Regional Fund-The regional fund will be subdivided into two parts.
(i) The State will annually calculate the share of each County within the State
of the regional fund utilizing the sliding scale in section 4 of the allocation
contained in the Negotiation Class Metrics or other metrics that the Parties
agree upon.
(ii) For Qualified Counties, the Qualified County's share will be paid to the
Qualified County and expended on Approved Purposes, including the
Core Strategies identified in Exhibit A, if applicable.
(iii) For all other Counties,the regional share for each County will be paid to
the Managing Entities providing service for that County. The Managing
Entities will be required to expend the monies on Approved Purposes,
including the Core Strategies. The Managing Entities shall endeavor to
the greatest extent possible to expend these monies on counties within
the State that are non-Qualified Counties and to ensure that there are
services in every County.
(c) State Fund - The remainder of Opioid Funds after deducting the costs of the
Expense Fund detailed in paragraph 9,the City/County Fund and the Regional Fund
will be expended by the State on Approved Purposes, including the provisions
related to Core Strategies, if applicable.
(d) To the extent that Opioid Funds are not appropriated and expended in a year by the
State, the State shall identify the investments where settlement funds will be
deposited. Any gains, profits, or interest accrued from the deposit of the Opioid
Funds to the extent that any funds are not appropriated and expended within a
calendar year, shall be the sole property of the Party that was entitled to the initial
deposit.
4. Regional Fund Sliding Scale- The Regional Fund shall be calculated by utilizing
the following sliding scale of the Opioid Funds available in any year:
A. Years 1-6: 40%
B. Years 7-9: 35%
C. Years 10-12: 34%
D. Years 13-15: 33%
E. Years 16-18: 30%
5. Opioid Abatement Taskforce or Council - The State will create an Opioid
Abatement Taskforce or Council (sometimes hereinafter "Taskforce" or"Council")to advise the
Governor, the Legislature, Florida's Department of Children and Families ("DCF"), and Local
Governments on the priorities that should be addressed as part of the opioid epidemic and to review
how monies have been spent and the results that have been achieved with Opioid Funds.
(a) Size-The Taskforce or Council shall have ten Members equally balanced between
the State and the Local Governments.
(b) Appointments Local Governments - Two Municipality representatives will be
appointed by or through Florida League of Cities. Two county representatives,one
from a Qualified County and one from a county within the State that is not a
Qualified County, will be appointed by or through the Florida Association of
Counties. The final representative will alternate every two years between being a
county representative (appointed by or through Florida Association of Counties) or
a Municipality representative (appointed by or through the Florida League of
Cities). One Municipality representative must be from a city of less than 50,000
people. One county representative must be from a county less than 200,000 people
and the other county representative must be from a county whose population
exceeds 200,000 people.
(c) Appointments State-
(i) The Governor shall appoint two Members.
(ii) The Speaker of the House shall appoint one Member.
(iii) The Senate President shall appoint one Member.
(iv) The Attorney General or her designee shall be a Member.
(d) Chair - The Attorney General or designee shall be the chair of the Taskforce or
Council.
(e) Term-Members will be appointed to serve a two-year term.
(f) Support-DCF shall support the Taskforce or Council and the Taskforce or Council
shall be administratively housed in DCF.
(g) Meetings - The Taskforce or Council shall meet quarterly in person or virtually
using communications media technology as defined in section 120.54(5)(b)(2),
Florida Statutes.
(h) Reporting - The Taskforce or Council shall provide and publish a report annually
no later than November 30th or the first business day after November 30th, if
November 30th falls on a weekend or is otherwise not a business day. The report
shall contain information on how monies were spent the previous fiscal year by the
State, each of the Qualified Counties, each of the Managing Entities, and each of
the Local Governments. It shall also contain recommendations to the Governor,
the Legislature, and Local Governments for priorities among the Approved
Purposes for how monies should be spent the coming fiscal year to respond to the
opioid epidemic.
(i) Accountability - Prior to July 1st of each year, the State and each of the Local
Governments shall provide information to DCF about how they intend to expend
Opioid Funds in the upcoming fiscal year. The State and each of the Local
Government shall report its expenditures to DCF no later than August 31st for the
previous fiscal year. The Taskforce or Council will set other data sets that need to
be reported to DCF to demonstrate the effectiveness of Approved Purposes. All
programs and expenditures shall be audited annually in a similar fashion to
SAMHSA programs. Local Governments shall respond and provide documents to
any reasonable requests from the State for data or information about programs
receiving Opioid Funds. •
(j) Conflict of Interest-All Members shall adhere to the rules,regulations and laws of
Florida including, but not limited to, Florida Statute §112.311, concerning the
disclosure of conflicts of interest and recusal from discussions or votes on
conflicted matters.
6. Administrative Costs- The State may take no more than a 5% administrative fee
from the State Fund ("Administrative Costs") and any Regional Fund that it administers for
counties that are not Qualified Counties. Each Qualified County may take no more than a 5%
administrative fee from its share of the Regional Funds.
7. Negotiation of Non-Multistate Settlements-If the State begins negotiations with
a Pharmaceutical Supply Chain Participant that is separate and apart from a multi-state negotiation,
the State shall include Local Governments that are a part of the Negotiating Committee in such
negotiations. No Settlement shall be recommended or accepted without the affirmative votes of
both the State and Local Government representatives of the Negotiating Committee.
8. Negotiation of Multistate or Local Government Settlements - To the extent
practicable and allowed by other parties to a negotiation, both Parties agree to communicate with
members of the Negotiation Committee regarding the terms of any other Pharmaceutical Supply
Chain Participant Settlement.
9. Expense Fund-The Parties agree that in any negotiation every effort shall be made
to cause Pharmaceutical Supply Chain Participants to pay costs of litigation, including attorneys'
fees, in addition to any agreed to Opioid Funds in the Settlement. To the extent that a fund
sufficient to pay the entirety of all contingency fee contracts for Local Governments in the State
of Florida is not created as part of a Settlement by a Pharmaceutical Supply Chain Participant,the
Parties agree that an additional expense fund for attorneys who represent Local Governments
(herein "Expense Fund") shall be created out of the City/County fund for the purpose of paying
the hard costs of a litigating Local Government and then paying attorneys' fees.
(a) The Source of Funds for the Expense Fund- Money for the Expense Fund shall be
sourced exclusively from the City/County Fund.
(b) The Amount of the Expense Fund- The State recognizes the value litigating Local
Governments bring to the State of Florida in connection with the Settlement
because their participation increases the amount Incentive Payments due from each
Pharmaceutical Supply Chain Participant. In recognition of that value,the amount
of funds that shall be deposited into the Expense fund shall be contingent upon on
the percentage of litigating Local Government participation in the Settlement,
according to the following table:
Litigating Local Government Amount that shall be paid
Participation in the into the Expense Fund
Settlement(by percentage of from (and as a percentage
the population) of)the City/County fund
96 to 100% 10%
91 to 95% 7.5%
86 to 90% 5%
85% 2.5%
Less than 85% 0%
If fewer than 85% percent of the litigating Local Governments (by population)
participate,then the Expense Fund shall not be funded,and this Section of the MOU
shall be null and void.
(c) The Timing of Payments into the Expense Fund- Although the amount of the
Expense Fund shall be calculated based on the entirety of payments due to the
City/County fund over a ten to eighteen year period, the Expense Fund shall be
funded entirely from payments made by Pharmaceutical Supply Chain Participants
during the first two years of the Settlement. Accordingly, to offset the amounts
being paid from the City/County to the Expense Fund in the first two years,
Counties or Municipalities may borrow from the Regional Fund during the first two
years and pay the borrowed amounts back to the Regional Fund during years three,
four, and five.
For the avoidance of doubt, the following provides an illustrative example regarding the
calculation of payments and amounts that may be borrowed under the terms of this MOU,
consistent with the provisions of this Section:
Opioid Funds due to State of Florida and Local Governments (over 10 to 18 years): $1,000
Litigating Local Government Participation: 100%
City/County Fund (over 10 to 18 years): $150
Expense Fund (paid over 2 years): $15
Amount Paid to Expense Fund in 1st year: $7.5
Amount Paid to Expense Fund in 2nd year $7.5
Amount that may be borrowed from Regional Fund in 1st year: $7.5
Amount that may be borrowed from Regional Fund in 2nd year: $7.5
Amount that must be paid back to Regional Fund in 3rd year: $5
Amount that must be paid back to Regional Fund in 4th year: $5
Amount that must be paid back to Regional Fund in 5th year: $5
(d) Creation of and Jurisdiction over the Expense Fund- The Expense Fund shall be
established, consistent with the provisions of this Section of the MOU,by order of
the Circuit Court of the Sixth Judicial Circuit in and for Pasco County,West Pasco
Division New Port Richey,Florida, in the matter of The State of Florida, Office of
the Attorney General, Department of Legal Affairs v. Purdue Pharma L.P., et al.,
Case No. 2018-CA-001438 (the "Court"). The Court shall have jurisdiction over
the Expense Fund, including authority to allocate and disburse amounts from the
Expense Fund and to resolve any disputes concerning the Expense Fund.
(e) Allocation of Payments to Counsel from the Expense Fund- As part of the order
establishing the Expense Fund, counsel for the litigating Local Governments shall
seek to have the Court appoint a third-neutral to serve as a special master for
purposes of allocating the Expense Fund. Within 30 days of entry of the order
appointing a special master for the Expense Fund, any counsel who intend to seek
an award from the Expense Fund shall provide the copies of their contingency fee
contracts to the special master. The special master shall then build a mathematical
model,which shall be based on each litigating Local Government's share under the
Negotiation Class Metrics and the rate set forth in their contingency contracts, to
calculate a proposed award for each litigating Local Government who timely
provided a copy of its contingency contract.
10. Dispute resolution-Any one or more of the Local Governments or the State may
object to an allocation or expenditure of Opioid Funds solely on the basis that the allocation or
expenditure at issue (a) is inconsistent with the Approved Purposes; (b) is inconsistent with the
distribution scheme as provided in paragraph 3, or(c)violates the limitations set forth herein with
respect to administrative costs or the Expense Fund. There shall be no other basis for bringing an
objection to the approval of an allocation or expenditure of Opioid Funds.
Schedule A
Core Strategies
States and Qualifying Block Grantees shall choose from among the abatement strategies listed in
Schedule B.However,priority shall be given to the following core abatement strategies ("Core
Strategies")[, such that a minimum of_% of the [aggregate] state-level abatement distributions shall
be spent on [one or more of]them annually].1
A.Naloxone or other FDA-approved drug to reverse opioid overdoses
1. Expand training for first responders, schools, community support groups and families; and
2. Increase distribution to individuals who are uninsured or whose insurance does not cover the needed
service.
B.Medication-Assisted Treatment("MAT")Distribution and other opioid-related treatment
1. Increase distribution of MAT to non-Medicaid eligible or uninsured individuals;
2.Provide education to school-based and youth-focused programs that discourage or prevent misuse;
3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement,
and other first responders; and
4.Treatment and Recovery Support Services such as residential and inpatient treatment, intensive
outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate
medication with other support services.
C.Pregnant&Postpartum Women
1.Expand Screening, Brief Intervention, and Referral to Treatment("SBIRT") services to non-
Medicaid eligible or uninsured pregnant women;
2. Expand comprehensive evidence-based treatment and recovery services, including MAT, for women
with co-occurring Opioid Use Disorder("OUD") and other Substance Use Disorder("SUD")/Mental
Health disorders for uninsured individuals for up to 12 months postpartum; and
3.Provide comprehensive wrap-around services to individuals with Opioid Use Disorder(OUD)
including housing,transportation,job placement/training, and childcare.
D.Expanding Treatment for Neonatal Abstinence Syndrome
1.Expand comprehensive evidence-based and recovery support for NAS babies;
2.Expand services for better continuum of care with infant-need dyad; and
3.Expand long-term treatment and services for medical monitoring of NAS babies and their families.
1 As used in this Schedule A,words like"expand,""fund,""provide"or the like shall not indicate a preference for new or
existing programs. Priorities will be established through the mechanisms described in the Term Sheet.
1
E. Expansion of Warm Hand-off Programs and Recovery Services
1. Expand services such as navigators and on-call teams to begin MAT in hospital emergency
departments;
2. Expand warm hand-off services to transition to recovery services;
3. Broaden scope of recovery services to include co-occurring SUD or mental health conditions. ;
4. Provide comprehensive wrap-around services to individuals in recovery including housing,
transportation,job placement/training, and childcare; and
5. Hire additional social workers or other behavioral health workers to facilitate expansions above.
F.Treatment for Incarcerated Population
1. Provide evidence-based treatment and recovery support including MAT for persons with OUD and
co-occurring SUD/MH disorders within and transitioning out of the criminal justice system; and
2. Increase funding for jails to provide treatment to inmates with OUD.
G.Prevention Programs
1. Funding for media campaigns to prevent opioid use(similar to the FDA's "Real Cost"campaign to
prevent youth from misusing tobacco);
2.Funding for evidence-based prevention programs in schools.;
3.Funding for medical provider education and outreach regarding best prescribing practices for opioids
consistent with the 2016 CDC guidelines, including providers at hospitals (academic detailing);
4.Funding for community drug disposal programs; and
5. Funding and training for first responders to participate in pre-arrest diversion programs, post-
overdose response teams, or similar strategies that connect at-risk individuals to behavioral health
services and supports.
H.Expanding Syringe Service Programs
1.Provide comprehensive syringe services programs with more wrap-around services including linkage
to OUD treatment, access to sterile syringes, and linkage to care and treatment of infectious diseases.
I.Evidence-based data collection and research analyzing the effectiveness of the abatement strategies
within the State.
2
Schedule B
Approved Uses
PART ONE: TREATMENT
A. TREAT OPIOID USE DISORDER(OUD)
Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder or
Mental Health(SUD/MH) conditions through evidence-based or evidence-informed programs or
strategies that may include, but are not limited to,the following:2
1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, including all
forms of Medication-Assisted Treatment(MAT) approved by the U.S. Food and Drug Administration.
2. Support and reimburse evidence-based services that adhere to the American Society of Addiction
Medicine(ASAM) continuum of care for OUD and any co-occurring SUD/MH conditions
3. Expand telehealth to increase access to treatment for OUD and any co-occurring SUD/MH
conditions, including MAT, as well as counseling,psychiatric support, and other treatment and
recovery support services.
4. Improve oversight of Opioid Treatment Programs (OTPs)to assure evidence-based or evidence-
informed practices such as adequate methadone dosing and low threshold approaches to treatment.
5. Support mobile intervention,treatment, and recovery services, offered by qualified professionals and
service providers, such as peer recovery coaches, for persons with OUD and any co-occurring
SUD/MH conditions and for persons who have experienced an opioid overdose.
6. Treatment of trauma for individuals with OUD (e.g., violence, sexual assault,human trafficking, or
adverse childhood experiences) and family members (e.g., surviving family members after an overdose
or overdose fatality), and training of health care personnel to identify and address such trauma.
7. Support evidence-based withdrawal management services for people with OUD and any co-
occurring mental health conditions.
8.Training on MAT for health care providers, first responders, students, or other supporting
professionals, such as peer recovery coaches or recovery outreach specialists, including telementoring
to assist community-based providers in rural or underserved areas.
9. Support workforce development for addiction professionals who work with persons with OUD and
any co-occurring SUD/MH conditions.
10.Fellowships for addiction medicine specialists for direct patient care, instructors, and clinical
research for treatments.
11. Scholarships and supports for behavioral health practitioners or workers involved in addressing
OUD and any co-occurring SUD or mental health conditions, including but not limited to training,
2 As used in this Schedule B,words like"expand,""fund,""provide"or the like shall not indicate a preference for new or
existing programs. Priorities will be established through the mechanisms described in the Term Sheet.
3
scholarships, fellowships, loan repayment programs, or other incentives for providers to work in rural
or underserved areas.
12. [Intentionally Blank—to be cleaned up later for numbering]
13.Provide funding and training for clinicians to obtain a waiver under the federal Drug Addiction
Treatment Act of 2000 (DATA 2000)to prescribe MAT for OUD, and provide technical assistance and
professional support to clinicians who have obtained a DATA 2000 waiver.
14.Dissemination of web-based training curricula, such as the American Academy of Addiction
Psychiatry's Provider Clinical Support Service-Opioids web-based training curriculum and
motivational interviewing.
15.Development and dissemination of new curricula, such as the American Academy of Addiction
Psychiatry's Provider Clinical Support Service for Medication-Assisted Treatment.
B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY
Support people in treatment for or recovery from OUD and any co-occurring SUD/MH conditions
through evidence-based or evidence-informed programs or strategies that may include, but are not
limited to,the following:
1.Provide comprehensive wrap-around services to individuals with OUD and any co-occurring
SUD/MH conditions, including housing,transportation, education,job placement,job training, or
childcare.
2.Provide the full continuum of care of treatment and recovery services for OUD and any co-occurring
SUD/MH conditions, including supportive housing, peer support services and counseling, community
navigators, case management, and connections to community-based services.
3.Provide counseling, peer-support, recovery case management and residential treatment with access to
medications for those who need it to persons with OUD and any co-occurring SUD/MH conditions.
4.Provide access to housing for people with OUD and any co-occurring SUD/MH conditions,
including supportive housing, recovery housing, housing assistance programs,training for housing
providers, or recovery housing programs that allow or integrate FDA-approved medication with other
support services.
5.Provide community support services, including social and legal services, to assist in
deinstitutionalizing persons with OUD and any co-occurring SUD/MH conditions.
6. Support or expand peer-recovery centers, which may include support groups, social events, computer
access, or other services for persons with OUD and any co-occurring SUD/MH conditions.
7. Provide or support transportation to treatment or recovery programs or services for persons with
OUD and any co-occurring SUD/MH conditions.
8.Provide employment training or educational services for persons in treatment for or recovery from
OUD and any co-occurring SUD/MH conditions.
4
9. Identify successful recovery programs such as physician,pilot, and college recovery programs, and
provide support and technical assistance to increase the number and capacity of high-quality programs
to help those in recovery.
10. Engage non-profits, faith-based communities, and community coalitions to support people in
treatment and recovery and to support family members in their efforts to support the person with OUD
in the family.
11.Training and development of procedures for government staff to appropriately interact and provide
social and other services to individuals with or in recovery from OUD, including reducing stigma.
12. Support stigma reduction efforts regarding treatment and support for persons with OUD, including
reducing the stigma on effective treatment.
13. Create or support culturally appropriate services and programs for persons with OUD and any co-
occurring SUD/MH conditions, including new Americans.
14. Create and/or support recovery high schools.
15.Hire or train behavioral health workers to provide or expand any of the services or supports listed
above.
C. CONNECT PEOPLE WHO NEED HELP TO THE HELP THEY NEED (CONNECTIONS
TO CARE)
Provide connections to care for people who have—or at risk of developing—OUD and any co-
occurring SUD/MII conditions through evidence-based or evidence-informed programs or strategies
that may include, but are not limited to,the following:
1. Ensure that health care providers are screening for OUD and other risk factors and know how to
appropriately counsel and treat(or refer if necessary) a patient for OUD treatment.
2. Fund Screening, Brief Intervention and Referral to Treatment(SBIRT) programs to reduce the
transition from use to disorders, including SBIRT services to pregnant women who are uninsured or not
eligible for Medicaid.
3. Provide training and long-term implementation of SBIRT in key systems (health, schools, colleges,
criminal justice, and probation), with a focus on youth and young adults when transition from misuse to
opioid disorder is common.
4. Purchase automated versions of SBIRT and support ongoing costs of the technology.
5. Expand services such as navigators and on-call teams to begin MAT in hospital emergency
departments.
6.Training for emergency room personnel treating opioid overdose patients on post-discharge planning,
including community referrals for MAT, recovery case management or support services.
7. Support hospital programs that transition persons with OUD and any co-occurring SUD/MH
conditions, or persons who have experienced an opioid overdose, into clinically-appropriate follow-up
care through a bridge clinic or similar approach.
5
8. Support crisis stabilization centers that serve as an alternative to hospital emergency departments for
persons with OUD and any co-occurring SUD/MH conditions or persons that have experienced an
opioid overdose.
9. Support the work of Emergency Medical Systems, including peer support specialists,to connect
individuals to treatment or other appropriate services following an opioid overdose or other opioid-
related adverse event.
10. Provide funding for peer support specialists or recovery coaches in emergency departments, detox
facilities,recovery centers, recovery housing, or similar settings; offer services, supports, or
connections to care to persons with OUD and any co-occurring SUD/MH conditions or to persons who
have experienced an opioid overdose.
11. Expand warm hand-off services to transition to recovery services.
12. Create or support school-based contacts that parents can engage with to seek immediate treatment
services for their child; and support prevention, intervention,treatment, and recovery programs focused
on young people.
13.Develop and support best practices on addressing OUD in the workplace.
14. Support assistance programs for health care providers with OUD.
15.Engage non-profits and the faith community as a system to support outreach for treatment.
16. Support centralized call centers that provide information and connections to appropriate services
and supports for persons with OUD and any co-occurring SUD/MH conditions.
D.ADDRESS THE NEEDS OF CRIMINAL-JUSTICE-INVOLVED PERSONS
Address the needs of persons with OUD and any co-occurring SUD/MH conditions who are involved
in, are at risk of becoming involved in, or are transitioning out of the criminal justice system through
evidence-based or evidence-informed programs or strategies that may include, but are not limited to,
the following:
1. Support pre-arrest or pre-arraignment diversion and deflection strategies for persons with OUD and
any co-occurring SUD/MH conditions, including established strategies such as:
a. Self-referral strategies such as the Angel Programs or the Police Assisted Addiction Recovery
Initiative(PAARI);
b.Active outreach strategies such as the Drug Abuse Response Team(DART)model;
c. "Naloxone Plus"strategies, which work to ensure that individuals who have received
naloxone to reverse the effects of an overdose are then linked to treatment programs or other
appropriate services;
d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion(LEAD)
model;
e. Officer intervention strategies such as the Leon County,Florida Adult Civil Citation Network
or the Chicago Westside Narcotics Diversion to Treatment Initiative; or
6
f. Co-responder and/or alternative responder models to address OUD-related 911 calls with
greater SUD expertise
2. Support pre-trial services that connect individuals with OUD and any co-occurring SUD/MH
conditions to evidence-informed treatment, including MAT, and related services.
3. Support treatment and recovery courts that provide evidence-based options for persons with OUD
and any co-occurring SUD/MII conditions
4. Provide evidence-informed treatment, including MAT, recovery support, harm reduction, or other
appropriate services to individuals with OUD and any co-occurring SUD/MH conditions who are
incarcerated in jail or prison.
5.Provide evidence-informed treatment, including MAT, recovery support, harm reduction, or other
appropriate services to individuals with OUD and any co-occurring SUD/MH conditions who are
leaving jail or prison have recently left jail or prison, are on probation or parole, are under community
corrections supervision, or are in re-entry programs or facilities.
6. Support critical time interventions (CTI), particularly for individuals living with dual-diagnosis
OUD/serious mental illness, and services for individuals who face immediate risks and service needs
and risks upon release from correctional settings.
7. Provide training on best practices for addressing the needs of criminal-justice-involved persons with
OUD and any co-occurring SUD/MH conditions to law enforcement, correctional, or judicial personnel
or to providers of treatment,recovery, harm reduction, case management, or other services offered in
connection with any of the strategies described in this section.
E.ADDRESS THE NEEDS OF PREGNANT OR PARENTING WOMEN AND THEIR
FANIILIES,INCLUDING BABIES WITH NEONATAL ABSTINENCE SYNDROME
Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH
conditions, and the needs of their families, including babies with neonatal abstinence syndrome(NAS),
through evidence-based or evidence-informed programs or strategies that may include, but are not
limited to,the following:
1. Support evidence-based or evidence-informed treatment, including MAT,recovery services and
supports, and prevention services for pregnant women—or women who could become pregnant—who
have OUD and any co-occurring SUD/MH conditions, and other measures to educate and provide
support to families affected by Neonatal Abstinence Syndrome.
2. Expand comprehensive evidence-based treatment and recovery services, including MAT, for
uninsured women with OUD and any co-occurring SUD/MH conditions for up to 12 months
postpartum.
3.Training for obstetricians or other healthcare personnel that work with pregnant women and their
families regarding treatment of OUD and any co-occurring SUD/MH conditions.
4. Expand comprehensive evidence-based treatment and recovery support for NAS babies; expand
services for better continuum of care with infant-need dyad; expand long-term treatment and services
for medical monitoring of NAS babies and their families.
7
5. Provide training to health care providers who work with pregnant or parenting women on best
practices for compliance with federal requirements that children born with Neonatal Abstinence
Syndrome get referred to appropriate services and receive a plan of safe care.
6. Child and family supports for parenting women with OUD and any co-occurring SUD/MH
conditions.
7.Enhanced family supports and child care services for parents with OUD and any co-occurring
SUD/MH conditions.
8. Provide enhanced support for children and family members suffering trauma as a result of addiction
in the family; and offer trauma-informed behavioral health treatment for adverse childhood events.
9. Offer home-based wrap-around services to persons with OUD and any co-occurring SUD/MH
conditions, including but not limited to parent skills training.
10. Support for Children's Services—Fund additional positions and services, including supportive
housing and other residential services, relating to children being removed from the home and/or placed
in foster care due to custodial opioid use.
PART TWO: PREVENTION
F.PREVENT OVER-PRESCRIBING AND ENSURE APPROPRIATE PRESCRIBING AND
DISPENSING OF OPIOIDS
Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of
opioids through evidence-based or evidence-informed programs or strategies that may include,but are
not limited to,the following:
1.Fund medical provider education and outreach regarding best prescribing practices for opioids
consistent with Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease
Control and Prevention, including providers at hospitals (academic detailing).
2.Training for health care providers regarding safe and responsible opioid prescribing, dosing, and
tapering patients off opioids.
3. Continuing Medical Education (CME) on appropriate prescribing of opioids.
4. Support for non-opioid pain treatment alternatives, including training providers to offer or refer to
multi-modal, evidence-informed treatment of pain.
5. Support enhancements or improvements to Prescription Drug Monitoring Programs (PDMPs),
including but not limited to improvements that:
a. Increase the number of prescribers using PDMPs;
b. Improve point-of-care decision-making by increasing the quantity, quality, or format of data
available to prescribers using PDMPs, by improving the interface that prescribers use to access
PDMP data, or both; or
8
c.Enable states to use PDMP data in support of surveillance or intervention strategies, including
MAT referrals and follow-up for individuals identified within PDMP data as likely to
experience OUD in a manner that complies with all relevant privacy and security laws and rules.
6.Ensuring PDMPs incorporate available overdose/naloxone deployment data, including the United
States Department of Transportation's Emergency Medical Technician overdose database in a manner
that complies with all relevant privacy and security laws and rules.
7. Increase electronic prescribing to prevent diversion or forgery.
8.Educate Dispensers on appropriate opioid dispensing.
G.PREVENT MISUSE OF OPIOIDS
Support efforts to discourage or prevent misuse of opioids through evidence-based or evidence-
informed programs or strategies that may include, but are not limited to,the following:
1. Fund media campaigns to prevent opioid misuse.
2. Corrective advertising or affirmative public education campaigns based on evidence.
3.Public education relating to drug disposal.
4.Drug take-back disposal or destruction programs.
5. Fund community anti-drug coalitions that engage in drug prevention efforts.
6. Support community coalitions in implementing evidence-informed prevention, such as reduced
social access and physical access, stigma reduction—including staffing, educational campaigns, support
for people in treatment or recovery, or training of coalitions in evidence-informed implementation,
including the Strategic Prevention Framework developed by the U.S. Substance Abuse and Mental
Health Services Administration (SAMHSA).
7.Engage non-profits and faith-based communities as systems to support prevention.
8. Fund evidence-based prevention programs in schools or evidence-informed school and community
education programs and campaigns for students, families, school employees, school athletic programs,
parent-teacher and student associations, and others.
9. School-based or youth-focused programs or strategies that have demonstrated effectiveness in
preventing drug misuse and seem likely to be effective in preventing the uptake and use of opioids.
10. Create of support community-based education or intervention services for families,youth, and
adolescents at risk for OUD and any co-occurring SUD/MH conditions.
11. Support evidence-informed programs or curricula to address mental health needs of young people
who may be at risk of misusing opioids or other drugs, including emotional modulation and resilience
skills.
12. Support greater access to mental health services and supports for young people, including services
and supports provided by school nurses, behavioral health workers or other school staff,to address
9
mental health needs in young people that(when not properly addressed) increase the risk of opioid or
other drug misuse.
H.PREVENT OVERDOSE DEATHS AND OTHER HARMS (HARM REDUCTION)
Support efforts to prevent or reduce overdose deaths or other opioid-related harms through evidence-
based or evidence-informed programs or strategies that may include, but are not limited to,the
following:
1. Increase availability and distribution of naloxone and other drugs that treat overdoses for first
responders, overdose patients, individuals with OUD and their friends and family members, individuals
at high risk of overdose, schools, community navigators and outreach workers, persons being released
from jail or prison, or other members of the general public.
2. Public health entities provide free naloxone to anyone in the community
3. Training and education regarding naloxone and other drugs that treat overdoses for first responders,
overdose patients, patients taking opioids, families, schools, community support groups, and other
members of the general public.
4.Enable school nurses and other school staff to respond to opioid overdoses, and provide them with
naloxone,training, and support.
5.Expand, improve, or develop data tracking software and applications for overdoses/naloxone
revivals.
6. Public education relating to emergency responses to overdoses.
7.Public education relating to immunity and Good Samaritan laws.
8. Educate first responders regarding the existence and operation of immunity and Good Samaritan
laws.
9. Syringe service programs and other evidence-informed programs to reduce harms associated with
intravenous drug use, including supplies, staffing, space, peer support services, referrals to treatment,
fentanyl checking, connections to care, and the full range of harm reduction and treatment services
provided by these programs.
10.Expand access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting
from intravenous opioid use.
11. Support mobile units that offer or provide referrals to harm reduction services,treatment, recovery
supports, health care, or other appropriate services to persons that use opioids or persons with OUD and
any co-occurring SUD/MH conditions.
12.Provide training in harm reduction strategies to health care providers, students,peer recovery
coaches,recovery outreach specialists, or other professionals that provide care to persons who use
opioids or persons with OUD and any co-occurring SUD/MH conditions.
13. Support screening for fentanyl in routine clinical toxicology testing.
10
PART THREE: OTHER STRATEGIES
I.FIRST RESPONDERS
In addition to items in sections C, D, and H relating to first responders, support the following:
1. Educate law enforcement or other first responders regarding appropriate practices and precautions
when dealing with fentanyl or other drugs.
2.Provision of wellness and support services for first responders and others who experience secondary
trauma associated with opioid-related emergency events.
J.LEADERSHIP,PLANNING AND COORDINATION
Support efforts to provide leadership, planning, coordination, facilitation,training and technical
assistance to abate the opioid epidemic through activities, programs, or strategies that may include, but
are not limited to,the following:
1. Statewide, regional, local, or community regional planning to identify root causes of addiction and
overdose, goals for reducing harms related to the opioid epidemic, and areas and populations with the
greatest needs for treatment intervention services;to support training and technical assistance; or to
support other strategies to abate the opioid epidemic described in this opioid abatement strategy list.
2.A dashboard to share reports, recommendations, or plans to spend opioid settlement funds;to show
how opioid settlement funds have been spent;to report program or strategy outcomes; or to track, share,
or visualize key opioid-related or health-related indicators and supports as identified through
collaborative statewide,regional, local, or community processes.
3. Invest in infrastructure or staffing at government or not-for-profit agencies to support collaborative,
cross-system coordination with the purpose of preventing overprescribing, opioid misuse, or opioid
overdoses,treating those with OUD and any co-occurring SUD/MH conditions, supporting them in
treatment or recovery, connecting them to care, or implementing other strategies to abate the opioid
epidemic described in this opioid abatement strategy list.
4. Provide resources to staff government oversight and management of opioid abatement programs.
K. TRAINING
In addition to the training referred to throughout this document, support training to abate the opioid
epidemic through activities,programs, or strategies that may include,but are not limited to,the
following:
1.Provide funding for staff training or networking programs and services to improve the capability of
government, community, and not-for-profit entities to abate the opioid crisis.
2. Support infrastructure and staffing for collaborative cross-system coordination to prevent opioid
misuse,prevent overdoses, and treat those with OUD and any co-occurring SUD/MH conditions, or
implement other strategies to abate the opioid epidemic described in this opioid abatement strategy list
(e.g., health care,primary care, pharmacies, PDMPs, etc.).
L.RESEARCH
11
Support opioid abatement research that may include,but is not limited to,the following:
1.Monitoring, surveillance, data collection, and evaluation of programs and strategies described in this
opioid abatement strategy list.
2.Research non-opioid treatment of chronic pain.
3.Research on improved service delivery for modalities such as SBIRT that demonstrate promising but
mixed results in populations vulnerable to opioid use disorders.
4.Research on novel harm reduction and prevention efforts such as the provision of fentanyl test strips.
5.Research on innovative supply-side enforcement efforts such as improved detection of mail-based
delivery of synthetic opioids.
6. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within criminal
justice populations that build upon promising approaches used to address other substances (e.g.Hawaii
HOPE and Dakota 24/7).
7. Epidemiological surveillance of OUD-related behaviors in critical populations including individuals
entering the criminal justice system, including but not limited to approaches modeled on the Arrestee
Drug Abuse Monitoring (ADAM) system.
8. Qualitative and quantitative research regarding public health risks and harm reduction opportunities
within illicit drug markets, including surveys of market participants who sell or distribute illicit opioids.
9. Geospatial analysis of access barriers to MAT and their association with treatment engagement and
treatment outcomes.
12
City/County Fund 15%
Regional Fund 35%
Scenario 1 $ 130,000,000.00
City/County Fund Scenario
1 $ 19,500,000.00
Regional Fund Scenario 1 $ 45,500,000.00
Scenario 2 $ 100,000,000.00
City/County Fund Scenario
2 $ 15,000,00000
Regional Fund Scenario 2 $ 35,000,000.00
Scenario 3 $ 70,000,000.00
City/County Fund Scenario
3 $ 10,500,000.00
Regional Fund Scenario 3 $ 24,500,000.00
Scenario 1 Scenario Scenario 2 . Scenario 2 - Scenario 3 • -.Scenario
(County (Allocated Subdivisions 'Overall Total% 'Allocated%by entity City/County Fund Regional Fund City/County Fund -'Regionaf Fund City/County Fund Regional Fund
Alachua 1.241060164449% $• -564,682.37 • $ - .434,371:06• $' -. 304,059.74
Alachua County 0.821689546303% $ 160,229.46 .. ._. .. __ $ 123,253.43 • - : $ 86,277,40 - • --
Alachua 0.013113332457% S 2,557.10 . .. $ 1,967.00 • _ _ .._- $ 1,376.90
Archer 0.000219705515% $ 42.84 - . . $ 32.96 - - . $ 23.07 . - .
Gainesville 0.381597611347% $ 74,411.53 • $ 57,239.64
Hawthorne 0.000270546460% $ '5236 • - . $ 40.58 - $ 28.41
High Springs 0.011987568663% $ • 2,337.58 , __ . . ; $ 1,798.14 '. _ _ . $ 1,258.69 - _ ,
La Crosse 0.000975056706% $ 190.14 $ 146.26 - $ 102.38 , .
Mlonapy 0.002113530737% $ 412.14 , - S 317.03 $ 221.92 ' ' - -
Newberry 0.006102729215% $ 1,190.03 $ 915.41 • $ 640.79
Waldo 0.002988721299% $ 582.80 . _ $ 448.31 $ 313.82
Baker 0.193173804130% - 3 87,894.08 $ - 67,610.83 $ ' ' 47,327.58
Baker County 0.169449240037% $ 33,042.60 •' $ 25,417.39 $ 17,792.17
Glen St.Mary 0.000096234647% $ •18.77. .... i $ •14.44 .. $ 10.10 .. .. _
Macctenny 0.023628329446% $•" 4,607.52 - - $ 3,544.25 $ 2,480.97 - . '•
Bay 0.839656373312% •$. ..382,043.65 .$- . 293,879.73 $ .. .205,715:81-
BayCounty 0.508772605155% $ 99,210.66 "' S 76,315.89 ' $ 53,421.12 '
Callaway 0.024953825527% $ 4,866.00 $. '3,743.07 _ - $ 2,620.15
Lynn Haven 0.039205632015% $ 7,645.10 - - $ 5,880.84 - S 4,116.59 '
Mexico Beach 0.005614292988% $ 1,094.79 _ .. .- -..__.-._._. $ 842.14 ' - __ ' S 589.50 - _ .
Panama City 0.155153 85 559 6% $ 30,255.00 $ 23,273.08 - - 5 16,291.15 ' '
Panama City Beach 0.080897023117% $ 15,774.92. - _ $ 12,134.55 ' -
Parker 0.008704696178% $ -
Springfield 0.016354442736%
Bradford 0.189484204081% $ -.:86,215.31. $ 66,319.47, S - 46,423.63
Bradford County 0.15142430909096 $ 29,527.74 $ 22,713.65 $ 15,899.55 . .
Brooker 0,000424885045% $ 82.85 .. ._. .. $ 63.73 . , $ 44.61 _
Hampton 0.002839829959% $ 553.77 - - $ 425.97 ' - $ 298,16
Lawtoy 0.003400896108% $ fi63.17 .. ... .- $ 510.13 .. - ,. .., 5 357.09 • - . ,
Starke 0.031392468132% $ - 6,121.53 . ,. , S 4,708.87 - - • $ 3,296.21
Brevard 3.878799180444% . ,S•. - '1;764,853.63, $. 1,357,579.71, 5' - 950,305.80
Brevard County 2.323022668525% $ 452,989.42 r • • $ • 348,453.40 $ 243,917.38 . _ .
Cape Canaveral 0.045560750209% $ -
Cocoa 0.149245411423% $ 29,102386 - $ -22,386.81 - .. $ 15,670.77 _ . - . ,
Cocoa Beach 0,084363286155% $ 16,450.84 ., $ • 12,654:49 '
Grant-Velkaria 0.000321387406% $ 62.67 - S 46.21 S 33.75 - •
Indialantio 0.024136738902% $' 4,706.66 - 5 . 3,620.51 • $ 253436 - '
Indian Harbour Beach 0.021089913665% $: - 4,11253 -• „ 5 3,163.49.', ' : $ 2,214.44 ,.
Malabar 0.002505732317% $ 488.62 $ 375.66 $ 263.30
Melbourne 0.383104682233% $- 74,705.41 - 5 57,465.70 ._. .. $ 40,225.99
Melbourne Beach 0.012091066302% $ 2,357.76 - $ 1,813.66 • 5 1,269.56 ,
Melbourne Village 0.003782203200%'$
Palm Bay 0.404817397481% $ 78,939.39 -- - ' $ ' 60,722.61. _ __. - $ 42,505.83 .
Palm Shares 0.000127102364% 5- 24.78 _ . _ $ 19.07 . _ $ 1335 '.
Rockledge 0.096603243798% $ - 18,837.63 - - - . " '- $ 14,490.49 5 10,14334 ' ' ..
Satellite Beath 0.035975416224% 5. 7,015.21 - • $ 5,396.31 , . ' $ 3,777.42 '
Titusville 0.240056418924% $ 46,811.00 ' $ 36,008.46 • . • $ 25,205.92 - .
West Melbourne 0.051997577066% $ 10,139.53 $ 7,799.64 - • $ 5,459.75
Broward 9.057962672578% •$ ' '4,121,373.02' 5• • 3,170,286.94 5 '2,219,200.65
Broward County 3.966403576878% $ 773,448.70 $ 594,960.54 - : " • $ 416,47238
Coconut Creek 0.101131719446% $ 19,720.69 .. _ $ 15,169.76 . . . . $
Cooper City 0.073935445073% $ - •14,417.41 " - - - $ 11,090.32 - - - • $ 7,763.22
Coral Springs 0.323 406517 6 6 4% $ 63,064.27 ' - ' ,_ ' S 48,510.98', - , $ 33,957.68 ' ,
_ _ Dania Beach _ 0.017807041180% $ 3,472.37 $ 2,671,06 $ 1,869.74 . ' - '
Davie 0.266922227153% $. .52,049.83 $ 40,038.33 $ 26,026.83
Deerfield Beach 0,202423224725% $ 39,472.53 . • - - - S- 30,363.48 $ 21,254.44 -Fort Lauderdale 0.830581264531% $ 161,963.35 S 124,587.19
Hallandale Beach 0.154950491814% $ 30,215.35 ' 5• 23,242.57 • $ 16,269.80
Hillsboro Beach 0,012407006463% $' 2,419.37 -• "'-' $ 1,861.05 , - $ 1,302.74 . '
Hollywood 0.520164608456% $ 301,432.10 - '• -• .._ $. 78,024.69 .. $ 54,617.28 -
Lauderdale-By-The-Sea 0.022807611325% $ 4,447.48 "' - -- - S 3,421.14 1 .. -. $ 2,394.80 -
Lauderdale Lakes 0.062625150435% $ 12,211.90 $ 9,393.77 $ 6,575.64
Lauderhill 0.14 43 828 3 813 0% 5 28,154.65 $ 21,657.43 5 15,160.20
Lazy Lake 0.000021788977% $ 4.25 5 3.27 $ 2.29
Lighthouse Point 0.029131861803% 5 5,680.71 $ 4,369.78 $ 3,058.85
Margate 0.143683775129% 5 28,018.34 $ 21,552.57 $ 15,086.80
Miramar 0.279280208419% $ 54,459.64 $ 41,89203 5 29,324.42
North Lauderdale 0.066069624496% 5 12,883.58 $ 9,910.44 $ 6,937.31
Oakland Park 0.100430840699% $ 19,584.01 $ 15,064.63 $ 10,545.24
Ocean Breeze 0.005381877237% $ 1,049.47 $ 807.28 $ 565.10
Parkland 0.045804060448% 5 8,931.79 $ 6,870.61 $ 4,809.43
Pembroke Park 0.024597938908% $ 4,796.60 $ 3,689.69 $ 2,582.78
Pembroke Pines 0.462832363603% $ 90,252.31 $ 69,424.85 $ 48,597.40
Plantation 0.213918725564% $ 41,714.15 $ 32,087.81 $ 22,461.47
Pompano Beach 0.335472163493% $ 65,417.07 $ 50,320.82 $ 35,224.58
Sea Ranch Lakes 0.005024174870% $ 979.71 $ 753.63 $ 527.54
Southwest Ranches 0.025979723178% $ 5,066.05 $ 3,896.96 5 2,727.87
Sunrise 0.28607110614696 $ 55,783.87 $ 42,910.67 5 30,037.47
Tamarac 0.134492458472% $ 26,22603 $ 20,173.87 $ 14,121.71
Weston 0.138637811283% $ 27,034.37 $ 20,795.67 $ 14,556.97
West Park 0 029553115352% $ 5,762.86 $ 4,432.97 $ 3,103.08
Wilton Manors 0031630331127% $ 6,167.91 $ 4,744.55 $ 3,321.18
Calhoun 0.047127740781% $ 21,443.12 $ 16,494.71 5 11,546.30
Calhoun County 0038866087128% $ 7,578.89 5 5,829.91 $ 4,080.94
Altha 0.000 3 6 67 81107% $ 71.52 $ 55.02 $ 38.51
Blountstown 0007896688293% 5 1,539.85 $ 1,184.50 $ 829.15
Charlotte 0.737346233376% $ 335,492.54 $ 258,071.18 $ 180,649.83
Charlotte County 0.690225755587% 5 134,594.02 $ 103,533.86 $ 72,473.70
Punta Gorda 0.047120477 7 8 9% $ 9,188.49 $ 7,068.07 5 4,947.65
Citrus 0.969645776606% 5 441,188.83 $ 339,376.02 $ 237,563.22
Citrus County 0.929715661117% $ 181,294.55 $ 139,457.35 $ 97,620.14
Crystal River 0.021928789266% $ 4,276.11 $ 3,289.32 $ 2,302.52
Inverness 0.01 80013 2 62 2 2% $ 3,510.26 5 2,700.20 $ 1,890.14
Clay 1.193429461456% $ 543,010.40 $ 417,700.31 $ 292,390.22
Clay County 1.055764891131% $ 205,874.15 5 156,364.73 $ 110,855.31
Green Cove Springs 0.057762577142% $ 11,263.70 $ 8,664.39 5 6,065.07
Keystone Heights 0.000753535443% $ 146.94 $ 113.03 $ 79.12
Orange Park 0.078589207339% $ 15,324.90 $ 11,788.38 5 8,251.87
Penney Farms 0.000561066149% $ 109.41 $ 84.16 $ 58.91
Collier 1.551333376427% $ 705,856.69 $ 542,966.68 $ 380,076.68
Collier County 1.35467333603096 $ 264,161.30 $ 203,201.00 $ 142,240.70
Everglades 0.0001 4 88913 41% $ 29.03 $ 22.33 $ 15.63
Marco Island 0.062094952003% $ 12,108.52 $ 9,314.24 $ 6,519.97
Naples 0.134416197054% 5 26,211.16 $ 20,162.43 5 14,113.70
Columbia 0.446781150792% $ 203,285.42 5 156,373.40 $ 109,461.38
Columbia County 0.341867201373% 5 66,668.00 $ 51,263.08 $ 35,898.16
Fort White 0.000236047247% $ 46.03 5 35.41 $ 24.78
Lake City 0.104659717920% $ 20,408.64 $ 15,698.96 $ 10,989.27
Desoto 0.113640407802% $ 51,706.39 $ 39,774.14 $ 27,841.90
Desoto County 0096884684746% $ 113,892.51 $ 14,532.70 $ 10,172.89
Arcadia 0.016755723056% $ 3,267.37 $ 2,513.36 $ 1,759.35
Dixie 0.103744580900% $ 47,203.78 $ 36,310.60 5 25,417.42
Dixie County 0.098822087921% $ 19,270.31 $ 14,823.31 $ 10,376.32
Cross City 0.004639236282% $ 904.65 $ 695.89 5 487.12
Horseshoe Beach 0.000281440949% $ 54.88 5 42.22 $ 29.55
Duval 5.434975156935% 5 2,472,913.70 $ 1,902,241.30 5 1,331,568.91
Jacksonville 5.270570064997% 5 1,027,761.16 $ 790,585.51 5 553,409.86
Atlantic Beach 0.03 8 8915 07 601% $ 7,583.84 $ 5,833.73 $ 4,083.61
Baldwin 0.002251527589% $ 439.05 $ 337.73 $ 236.41
Jacksonville Beach 0.100447182431% $ 19,587.20 5 15,067.08 $ 10,546.95
Neptune Beach 0.022814874318% $ 4,448.90 5 3,422.23 $ 2,395.56
Escambia 1.341634449244% 5 610,443.67 $ 469,572.06, 5 328,700.44
Escamhla County 1.005860871574% 5 196,142.87 $ 150,879.13 $ 105,615.39
Century 0.005136751249% $ 1,001.67 $ 770.51 $ 539.36
Pensacola 0.330636826421% $ 64,474.18 5 49,595.52 $ 34,716.87
Flagler 0.389864712244% $ 177,388.44 5 136,452.65 $ 95,516.85
Flagler County 0.279755934409% $ 54,552.41 $ 41,963.39 $ 29,374.37
Beverly Beach 0.000154338585% $ 30.10 5 23.15 $ 16.21
Bunnell 0.009501809575% $ 1,852.65 $ 1,425.27 $ 997.69
Flagler Beach 0.015482883669% 5 3,019.16 $ 2,322.43 $ 1,625.70
Marineland 0.000114392127% 5 22.31 $ 17.16 $ 12.01
Palm Coast 0.084857169626% $ 16,547.15 $ 12,728.58 $ 8,910.00
Franklin 0.049911282550% $ 22,709.63 $ 17,468.95 5 12,228.26
Franklin County 0.046254365966% 5 9,019.60 $ 6,938.15 $ 4,856.71
Apalachicola 0.001768538606% 5 344.87 $ 265.28 $ 185.70
Carahelle 0.001888377978% $ 368.23 5 283.26 $ 198.28
Gadsden 0.123656074077% ,5 56,263.51 5 43,279.63 5 30,295.74
Gadsden County 0.090211810642% $ 17,591.30 5 13,531.77 $ 9,472.24
rZI'69T;1T, $ 99'615bI' . " $ - 569L0ZLLIT6TE90 anaAelel
. ' 46'6£6 $ -. Z9S89' .$ :. " 10109 $ %88L9LbL£LE00'0 .19.114o161
96 9b6'E 5 - " . ' 69LE9'5 $ - -' T6'8Z£C $ %T0069T485LE0'0 A1uno0 uovalla9
0£'T00b1 :$ ,HS'LBZb0 $ 58'ELS8T .. $ 9198LLb9TZ90490 u0va11a1
E4'052 $ 19'096 $' • 61.'894 $ %9040501,01/200'0 660069
• . 95%ICC $ ' , 56'LZ0'IT '$ EE'9£f4T $ %89L8E96159[0'0 uuepe44
- ZC'6 $ WET $ .-.., - .".- 'a- 90'81 $ %T5L509Z60000.0 a 6841e4.1
Z5'05 $ - - 8T'ZL $ : --' E9'E6 $ %SEZ£LTT80000'0 /IDgwer
SL'SET $ Z6'£6T $ .. OI'ZSZ $ %9L9Z98Z6ZT00'0 paomuaal0
. '• bZ'E $ ' - £9b $ Z0'9 . - $ %LILL980E0000'0 a8pppuel0
' '' Zb'E62 $ " LT'6I4 $ L6445 $ %L5Z9E14/6LZ00'0 alllnaa019
- LC'bii $ • 96'f9T $ .. STETZ $ %6ZE060E60T090 alepuoll40
WELT $ 0E'L7Z $ _ ' 05'TZE $ 964£26698491090 oo1l1a4d4e0
. " 89'9 $ - 9Z'6 $ — 40'ZT $ %4£1/5ELI90000'0 wwseg
-' 081E $ -' 89'S4 $ ` '' 'ET'65 - $ 9,5Z66LZ£0E000'0 p10119
44168'4 $ ;. ". - 9078Z'TT 5 .. 8999991 $ 9140LIEL£TZ5L0'0 A18440 uos4ael
£E'6E618E - -$' ,297Z9'65 - •$: 'T6STE2L' '" S %56L9S096685T'0 849pel
• " , 54'L9E'9 $ -- ' -- SE'9606 $ - 9Z'S28'II $ 66855FSFZ49090'0 44eae alai
, -' - LT'£Z01, $ 6E'LbLS - $ - 09'I44'4 $ %L9bST65TE8f0'0 uepsega5
$ 56TZ7T98906000'0 PI4410
5H859Z $ 9E'86L'E $ :. L9'L£6b $ %Z9EZ2bZZf5Z040 swags 1a618 uelpul
, 6Z'9I5 $ 95'LEL $ .. - Z8'856- $ 51bELS40LI6400'0 0.844483
, 00'SL4'S9 5 ZCSES'E6 $ ' - fb'965'TZI $ %LTZ09bTLSEZ9'0 A1uno0.18616 uelpul
69`60518T ' " •$ Z9'9L5'69L — ' $' - T9'649'Z9E - -'$. %T8L8509L0ESC'0 lanlyuelpul
.. •. L8'8T $ - - •. - 969Z $ - -- ' - 50'SE $ %L50654641000'0 allvNsaM
.- ' ' L8'9T $ ' 96'9Z $ "' SO'S£ $ %CS065L6LS000'0 6001 ap wood
' , - ZZ'9£T $ 7L'T6T $ ' LL'690 $ %TE998L8LZI00'0 muoN
- E£1859 $ ' -' ` - L9'Ob6• $ . S9'ZZZ'T $ %9608LL69Z900'0 4l63
•" 6Z'bZL $ ,OL'bE01 — 5 41E989Z086890013 Ae11u08
. - £5'410'L $ - - • SL•0Z001 $ - - - _ ' 86'920£T- 5 %654Z00506990'0 A48na0 sawl0H
40•566'6T. - $ 5£1,95'9Z ' $: ;59'Ef1'LE - . ... . $ 91I58LZ92I9T890 644644
• 86'LEE'TT 5 II'L6I'9T $ bi'9501Z $ %EITT0L086L0T'0 we.uay aldway
. ' 55544'L0Z $ - `' -' . 84'055'96Z .$ '-- " ' - Z095Z'S8E $ %£SZT88TL95L61 eduley
.. 96'Zb6'01 $ .;.LCZE9'ST - ,$ - - T9'ZZE'OZ $ %ZbIT6b8LZ40T'0 A1U14416
-— . 899Z6'489 $ 99996!8C6 $ — .- 89'900YLZI $ 96009900TIIEZS'9 A1uno04864l44slll6
-LI'I6L'bET'Z- $, 41,1443'860'E $ LL'L64'E96'E, $ %L59ETI4860TC'8 42..1.41111H
SI'800'b $ ' " ' - " C8'SZL'S '$ ` '_- - _ E9'£4bL $ %TLESL9ZLS0E0'0 24 41as
- ` 5£1415 $ ' - 64'4E9• $ . - = EZ'SH0'T • 5 %06LL92595500'0 PP01da4el
- ".$ %0609106285Z0'0 41ed UOO1l
$ bi'980'95 $ %98645CIZ9L8Z'0 Aluno7 spue6486.1
6T'.TTS'L9 .$ 186'SS0'SZT '5 LL'025'Z9I ' • $ - %LEZ0T588LLSE'0 68661421H
' 49'62T $ '- ' Inn $ ' "' LL'07Z $ 468L98049EZI00'0 amp eM fdaam
-- - . ' 95'8E4'9 $ ,". 96'C6T6 .5 EECS6TT $ 96£85LZ96i£I90'0 alll009006g
-. .. LL'686TST $ - 42'8LI'LTL $ SC'99Z'Z9Z 5 %698ZT9TZSL99'T Aluno7 opueWaH
-T9'896'69E- . '" $ 85'9Z518Z5' $' 95'480'L89,'.. ' 5; %0TT61,65C00T5'I opueuaH
` . 80'964 $ ! 69'80C $ `. ."' 6L1Z6 $ 96014,9LSbZL900'0 aI1.881
• 989761 $ L£'9E9'2 $ ' - 99'6Z4'£ - $ %7Ib15T685LT0'0 u0lslmal0
""' 5Y506YT $ ' " ..807ZE'8I $ =" -' OL'8T8EZ. - ' $ %E44L8TL9LZZT-0 /44..0 NpuaH
Z616E'SE $- Z0T95'05 . $ :2L62LS9. .. - $ %L6Z0T60944,7T'0 A131.10H
TL'T8 $ ZZ'90I $ %LTbb0Lbb5000'0 89405.110Z
` 80'001 $ TT'000'I, $ • `ST'00£'T - $ %0989L9L99900'0 einganeM
SLUT $ 99'69Z $ £5'05E - $ %5L5065C6LT00'0 uaa.ID 8uimog
' £500T'9 $ - 50'STL'8 $ : - ' 95'6ZE'IT $ 9608Z90600T850'0 A1un00aap.mH
96194'9L. - $ 1Z5'884'£Z $ L0'565'05 $ %LET8400LIL950 aapleH
" TZ'TLT $ ' BS'99Z $ ' ' 96'LLE $ 91145LI950£9100'0 8e8p464114M
' - - 69'SLZ $ • 95'E6E -$ ' - - - E9'TIS $ %04655LEZ9Z00'0 8841866r
'$ %58Z9£8698400'0 ladse(
'" - 6L'SC0'b $ " - - ' ; 95'ZZe'S $ • - EE'695'L ' ' ' $ %TE6T90LT88f0'0 616n43 601061e6
- 61,016561176L40'0 4.1111.H
' - _ . 400b $ . . 0Z'LS - '$ '—SEW "$ %260L0ET8f000.0 884,114...M
-' _' 08_SOS $ .-'-= 85'LZL $ ': '• S£'fi£6 $ %I656LTLT9400'0 a01'75114d
, - ST'S7L'S $ .' 9E'L0L'8 $ • - .. ' L5'689'0L $ %506T5L6TC450'0 44..38n9
66'8L9'bT. . "$ 96'696'02 $ ,86'09Z'LZ. $, %8859EZb16650'0 1109
. .. I0'0Z $ " L8'82 - $ ' .. - ' ' ' 1 £5'L£ ' $ 5146Z69416T000'0 89484aloow
- b1'bb0'b $ 90E909 $ - - ' L6188'L - 'S 91494L9E024040'0 A1una0 sapelg
ST'056'6 ' ' - $ 6b'bTZ'9T. '.- $ .08BLb8T '' - .. $, . %9549E8ZI9040'0 1.8019
L6'69Z $ ' - ' 99.58E $ ' • . .. ^ 9£'T05 $ %LbZ660TLS200'0 uolualy
OS'O4 $ 6Z'BS '$ " . - LC54 $ %4800L588E000'0 s8u11d58uluued
.. . 64'0I $ - 864T $ , '44'6I $ %EbT998660000'0 11.9
6L`EE9'9 $ - ' 7I-I6T'6 . $ . " .. , ` 841846'TT $ %T88££ZbLLI90'0 Aluno°lsllgall9
LL'I9L'ST - $ .Z8'9S5'ZZ • $ C8'TLZ'60- ' • •, $. 5655£69LE£E990'0 1'114.119
• , . - - ET'980'Z $ 6I'086'Z $ . .. . bZ1,48'E $ 91EZZST6L986T0'0 Aouln°
' IL'9ZT $ • • 06'08T $ . 6£'4EZ $ 96EL25Z0Z0ZT00'0 AemplW
' . ' ' 0E'ELS $ - - - 66'898 '$ 69'990L • $ 91E04156654500'0 eue68H
LZ'Sfi $ -. fi0'9EE $ ,-- Z69Eb $ %101669042Z00'0 ¢ulal9
. C9'TS $ -• - " IB'EL "$ .... - ., 56'S6 $ %ELLL90Z69000'0 alogsuaal9
- 80'6E0 $ • SZ'LZ9 • $ ... , Eb'SI8 $ %ZLCL99T8T400'0 6a44449elle43
225:
m \2(.f mr.6\.-iam }\(( ( (( 2
M .4.4- 6 ..- (\\(\(( (\\ \= 661 6 1.4.4,2{
„ ,,,,,,,,,, ,� ,,,, , „ ,,,,,,,,, „ ,,,, ,,,,,,, ,,,,,, ,,,,, ,,,,,,,,
( k \ \ ( \ \ \ \ \
R;a; ;
\E \)( \\(W EEE 0 (\\\(P( (\ \§rr.q.R) V. C`"K R\(/\\\ \\(1\A \\\\\ \\\§§(\\
„ ,,,,,,,,,,,,,,, ,,,,,,, „ ,,,,,,,,, ,. .,,, ,,,,,,, ----- ,,,,, ,,,,,,,,
\ \ \ \ k ( \ \ \ \
\¥ a mmHg @ ®
gg �� g�. , .� ° , "'\ § . . Rggg !/
�, „,,,,,,,,,,,,, ,,,,,,, „ ,.,,,,,,, „ ,,,, ,,,,,,, ,.,,,, ,,,,, ,,,,,,,,
,,,,,,,,Mg V4M6! «; ;:a§§/; , ,,,,,», ,,,, Iggg ,,, ,,
) §§§§()§))E§§;§ ^^`®n ; !2 \ ()§ )T.5..,� �. ,�P.,��.�� um»r:,2 §■ § ,®§:eG: R, ��� �. �. HH
*EIM 'Hgr ;[2 =\\ PEEHE\j\\\\UE \j\(§() \§ MgEg§§) j\ (\)) \\\\\\\ j§ hEn.: W.EER\\
f11 \ ]) L ! �&
T -- !, ! | : -
\\ _ \ \ A) , \ _ ) ]{{ 22,11 )\))\ \ / \j {\\\ f))\ n ) ! j)k )\\ HAM ){}\\\/
! 1 ] ! \ \ 2 \ \
SZ-L95'64 $ 9E'0T9'0L $ - L4'ESO'Z6 $ %T96E40690L44'0 uose8 12309
66'98EL $ • LZ'4LI'E $ - SS'T901, $ %5465448ZBOZ0'0 .P419.11.9
5E8961 $ 99'ZIEZ $ • . 64'959'E $ %69T06ZTSL9T0'0 sllueptl
65'4T0'E85 $ LZ'ZBEZEB $ 56.944'Z80'T $ %92064994SZ55'S A4uno04oeag wled
Z9'06E'40L'Z $ E0'9SS'OTO'E $ .bb'SZL'ET6'E $ %£SOZLE465T09'8 —
__ span u+led
E6'ZSL'L $ , T9'SL0'IT $ ' 6L'86E'bi $ %8L996£LE8ELO'0 Pno1075 _
E4'1140'LT $ •061.SE'42 $ , LE'T99'IE $ %Z4B90099E29I.0 wwlssq
TI'II6'49 $ OE'LBS'9ZI $ ' 6b'E92'E9I $ %0660698924E890 AlunoO slows°
94'566'292 $ 'EZ'80L'SLE ' $ 04'014'884 $ %046L60ZS6EC0'T 010ws0
ZS-6I0'II $ , 545EL'ST $ 60'954'OL . $ %65T8Z0E0690T'0 Ved.4141M
134'406'S $ 69'6E4'9 $ - • 66'1460T $ 9696660969L950'0 uape0 sump,
SSZ64 5 TLZEET S 431491 $ %499490966400'0 alawapuIM
6049Z9'TZT $ L2'LE0'44T $ 54.84Z'9LZ $ %06910696Z09T'I 0P11e1.10
86766'9 5 46696'6 $ 46'986'ZI $ 960Z6ZZ966$990'0 aw0
50.00S $ 9E'4T8 $ C9'850'L $ %9899806i6500'0 puepe0
44'9061/ $ 4L'600'4 S - MITES $ %60Z9LZBLL940'0 p4e111e1/4
0£'490'T $ BZ'ESS'I $! - LL`6I0'2 $ %S9ILTZSSEOTO'0 elslA euang awl
6I'020'T $ • T4'459'1 S • E9'468'T $ %509490914600'0 puomaep3
' SI'4L8 $ 84'844'I $ I4'FZ9'I $ %5E99025LE900'0 alllItu07e3
MEET'S $ 91'6T9'T S - -` - - 99'50EZ $ %989£5L136LOT0'0 alsl agag
691.44'L $ ' 669E5'f $ 69'5666 $ %6I0965995EZ0'0 °Nei Ae9
66-40Z'OI $ ' " CZZBS'4I $ - S6'9S6'8T $ %Z680STSTZ460'0 egdody
69'6b9'IZE $ 95'669'654 $ 66'64E'L65 $ %64698E0EEE901 Aluno0 a8ue,0
T61094/9t0 $ 1313'659.969'T $ 48'LTE'SZEZ $' %9145bIZBi0IL9'4 a9ue00
06'660'19 $ TL'Z48'S $ 6E565'4 $ %49ZLZPI569E0'0 0ag04oaa90
OI'4L0'06 $ 9SI3I'49 $ SO'9EE'T9 $ %504T513E14541E'0 Aluno°aago4oaa40
46'909'99 $ SE'£ZL'£ZT 'S ,SF'068'09T -$ %Z6994Z66685E10 aag0yo0a9O
46'460'T $ ES'895'T $ 60'6E0'Z $ %Z50E6139540T0'0 osleledleA
SEISE $ LL'ELZ S - ' 48'55E $'%96494814Z9100'0 0004104S
L6EBZ'Z $ • TB'T9i'E $ • SE'Ob6b $ %ETLB6ES6LIZCIO 4111.41N
bb'Z86 $ B4'E04'T $ • ES'bZ9'I 5 540E464695E600'0 "agls3 Aleut
6E13 S • 86'II $ 85'51 $ %4T6Z68640000'0 1144141.1
66-ZLEB 5 L9'SL9'TT $ • TE'BLT'ST $ %9494894E13440'0 yang u0310M pod-
' bi'IpS'T $ BC-IO2'Z $ TEL99'Z $ 96T8L4059496T0'0 u11sa0
• TE96E'L 5 ZO'99901 $ • • E8'SEL'EI S %9900ET094040'0 ma1alsa.0
ZO'LL $ E0'0TT $ 40'E9T $ %4TLZ9S££L000'0 noAe9 wup
9E99E99 $ 96'130816 $ E9'ISE'6TT $ %StSLI9650ZI9'O Aluno0 es0ol0M°
ST'LOC'00Z • $ .051464'99Z $ SET4L'ZL£" $ %SS6S99ZTZ6I8'0 eso0le00
' 94188 $ • 8E'9ZT $ 62'99T $ 95860LOS296000'0 P0e18H
4L1E4'8 $ '' L6'ELb'2I $ 60'91Z'9T $ %56156665IE80'0 4.34 eulpue 00i
49'EL $ WEE $ • 06'69 S %65LLSTSLL000'0 ue4e11e0
LI'4E214 $ 56506'95 $ - - • 4C'CLS'94 $ %1S6456904Z6E0 Alan°nesseN
OL'84B'9TT $ TC'9Z6'99T $ 64'900'4TZ . • $• 55L00699£E6949'0 nesseN
9Z'99E6 $ . IS'L£9'6 $ - 94'9Z0'9 • $ 56T6T2649I60E0'0 uo43e,ey4
ZEST $ I9ZZ $ 66'6Z $ %68040405I000'0 400401
• 8T'64Z'6 $ LT'fTi'EI $ . 60'44T'LT $ %4I4S9E480980'0 Isom AaM
. - 961669 $ LL'ZIL $ . 09'9Z6 $ 51199ZTBIS4400.0 yang AuoloO AaM
ZS'L6E'Z $ - 09'66E'6 $ - C9'65E'4 $ %90950010660O'0 epe00welsl
OT'E99'4E $ ZL'8IE64 $ £E'64E1.9 $ 1169951349LI0EE'0 Aluno0 a01a0p.1
PLSTL'9IT $ 90'964'99T • $ 813'954'91Z. $- %5958E41386944'0 a0.uo4y
4G'BLZ $ . 6T'e6E $ SECTS $ %459EL9959L00'0 1we115 Isom
9I'E6T $ 56'SLI $ . ECM $ %46Z£L6ZCTT00'0 4ua11le9 eIul8+lA
TL'L£4 $ 54'LT9 $ • - 89'209 $ %Z4800E9TT600'0 ualemlaams
EVILS $ SPOIL $ Z9'696 $ %59L9E5698400'0 o14+pf5
08'409 $ - 00'45T'T 5 OZ'005'I $ %TTSbZE669400'0 4peag sold Auuns
847Z9 $ 46'6CYT $ 94'4Z$'I $ %TTTLEIEE8400'0 Iw01151.5
• 0I'TC8 5 L4'b9i'T 5 - S4'4I9'T $ %99BLSI96Z1300'0 is0aauld
64744 $ - 69.0TET $ .. 06-Ebb'T $ %0L60Z940PL00'0 Ae9 ouawled
00'4Z8 $ - - SI'CCT'T $ ' - 6Z'OES'I $ %960E99498400'0 e4o1-ed0
9T'L6T'E $ 09'9SS'4 $ 69926'S - $ %606066T660E0'0 4oea6114e11444009
Z1E69E6 $ 69'9S5'4 $ -- • 96-E26'S $ %4T409Z64E060'0 Iw0IW 41'0N
413745 $ 50'444' $ - 4E9001 5 %44655E09T500•0 4ee111A 6404130N
49'499 $ 69'5Z6 $ ET'EOL'T $ %E68TT6691900'0 s9upd5lwelyy
E 2'099 $ 6T'E46 $ ' ST'9ZL'I 5 %9TSSE645Z900'0 sai0461.4194
98'ZL8 $ ZS'SLT'T $ LI'925'T $ %B099949E8400'0 4.141141e1LN
BL'ILY4 $ • SS'Z0I'9 $ TEEE6'L $ %ZE60596990170'0 su3p1e0lwe14y
., TO•840'6T $ 44'TIZ'LZ $ L644E'SE $ %1349Z4560908i'0 4oea9 lump,
LZ'E4C'OE $ S6'BT6E4 $ - 49'960'46 $ %8149500E6LL62'0 1we194
LS'9T6 $ • 4Z'ZIE'I $ - . T6'5041 $ %IET4LZOPL800'0 A0Ipa91
• 44'9E41 $ ZEZSO'Z $ 0418991 $ %996119899EI0'0 009004g AaM
TI'L9Z $ - 85'186 $ 50'969 $ %9Z0E98E6S200.0 Baal°uelpul
SZ'9T96 $ SE-ObL'E 5 99699'9 5 %990899066600'0 pealsawo8
ES-ZCS $ 06'419 $ ' • LZ'E90'I $ 96II4T69Z64500.0 suapue9 yeale1N
• (9'T6Z'0T $ 8E'20L'9T $ • OT'EII'6T $ %5945696E0860'0 4ea1e1N
46'96Z $ ' 949424 $ 8T'S55 $ %Tg6Z60498L00'0 4oeag uaplo0
CSZT4 $ 6E'686 $ _ TE994 $ %Z6404L6Z6E00'0 Alp ePP4li
- - 40'46 $ E9'8ET $ ZZ'09T $ %094STZ6Z6000'0 141.d 13
:98m
02WW22E2E0ACA§".4.H22 21 Rnm
.,..,.w wwwwwwwwwwwwww .,.w .,.www ww,,ww H w.., ...www...,. w...,.,. ..,wwwwww
o ry m
lae nSo Z8 r
w w w w w w w w w w w w w w w w w w w w w w n w w w w w w w w w w w w w w w w w w w w w w w w w w w w w w w w w w n w w w w w w w w w w w w w w w w
„Sm m2'< m82
ww nwwww.nw.,.w.nwwwwwwwwwww.n.nwwwwwwwwww wwwwwww wwwwwwwwwwwwwwww.nww.nw.,.www w wwwww
xra 5I eta°x1 V ggAgggg :axxaaa:4W4, e r�;eg4g V"1"a:xonam�mxa'a:a:�' m'°"M gAMIttl
�8° <S e82.
m§2EI ogosa^sso oao�o� oss sss§� oso ssonsso osss
$ 6 E_ __ Y Y _ a _ >E _E 'o L'Y c c Y¢ ` -
- -—- - — --—n 3 — 1 C $c E_E E_E m = a Y a =___ d v-'_ a Y E o. ` - o v i
m m A o u u x i x ?3 i i 3 3 f z o n.a a a a i c 3 3 a 2 z d N d m m m m u A 19 x S i z o a z t I N .=A °a'm o o w.°
8 =
- Sb'EZ $ OS'EE $ SSEb $ %TIOLEE£ZZ000'0 4aeag+agleid
E9'960'9 $ t .. ' £E'90L'8 $ ' ' EZ'BTE'TT $ %EbEZOZZbOBSO'0 +alema8p3
, 95.6Z6'0Z $ ' 8E'668'6Z $ - 6I'698'BE :$ %8E006T6L666T'0 euolla0
• 6Z'E6E'OL $ SS'L48bT $ ZB'IOE'6T $ %260699E86860'0 puele0
' - BC'bOL'E $ 1,5'ZSZ'S $ 'LEOH89 $ %STL9T9$8$SE0'0 Ale8a0
. ZO'£LL'b $ . • 96196'5 $ 06'64L'L $ %6EbE60E$6£0'0 swags tpeag euenAeO
Eb'E66'94 $ + ,, • L4'EET'C9 $ TS'ELZ'LB . $ %ZLZSLb9SSLVE,0 4aeag eualA.a
' - Tb'00b'6CT $ , OE'982'9SZ $ ' 6I'ZLT'£EE $ %LBZZbESLSBOL'I Aluno7 elsnloA
LL'OE6'99L $ 6E'ST9'560'L 5 00'00E'4Zb'T $' %0254496ZEOET'E elsnloA
. ['nit $ , "- " - '£4'CS $ 99'LZ $ %9L8LOZ9T1000'0 zHui+dg uo1HulgnoM
EFS $ IFS $ - 897' $ %9EZ0ILZT0000'0 1.6l1e9
' 08'90T $ ZL'60Z $ - - £9'ZLZ $ %E009ZTH6ET00'0 +apng awl
L0199'9 $ ' 6E11,5'6 $ ` •TL'L0b'ZI $ %60T6SZ6Z9E90'0 Aluno7 uoluf
6Z'E96'ST - $" TL'409Y2' ' " $ .ZI'999'61 -."' $' %9ZZEOE95T590'0 6.16n
9Z'2EE'Z $ ' TB'ISS'S $ 5E'TEE'9 $ %E96590ZILZZO'0 A++ad
£B'99E'L $ , Bb'S64'0T $ ZT'499'£T $ %6I£TSB696690'0 Alamo A:0u.
9S'685'ZZ "$ '99'E9L'ZE $ '9CZb6I4 "$ %Z8LL68TBTZ60'0 +alAeL
- - EO'TSO'E $ . , T9'85E1, $ .02999S $ %ZET9I9LSOSZ0'0 11606611
I9'L6 $ - 54'6ET $ ' BZ'TBT $ 56400E996Z6000'0 P+oluwg
, Z6'406'91 $ LT'b5T'7Z' $ •' 2b006TE $ %555008L20I9I'0 Aluno7 aauuemn5
59'86L'9b -$ 'TL'SS2'99 " $- CLTT69H ' $ %Z696LBbT0T6T'0 aauuemn5
9S'EL9'T $ • 60'SOI'L $ •- T9'9EC'Z ' $ %TZL9T6E£09T0'0 Po..P0M
4b'64S $ ES'ELZ $ ; • - - 65LLZ $ %9L4995EL7T00'0 +alzgaM
' SS'IL $ ' • IZZIT $ 88'S9T' $ %66188080L000•0 ewalo7
' 9B'LET $ Z6'96T 5 • - 6E55Z $ %bbBSBLZIET00.0 IIIH+alum
6C'£69 $ ' £T'T66 $ 99'9BZ'S $ 660LTLO0L09900'0 IIau4s'8
" $9'8EL'TE $ SE07E'S9 $ ' • ' " ' 4Z'£96'BS $ %9909Z0£LZZOE'0 Alamo Javans
ZL'L96'64. $ -09'6£2'bIT $ ' 69'TTS'BbT. , $ %6SbOL886E9ZE0 +alwn5
. - Z6'ET $ , , 8B'6T $ , - 58'SZ $ %90969S0ET000'0 a8e01Aannl'IS
' 9E9£0'T9 $ ' - ZS'0L9'85 $ - L9'90Z9L • $ %6B6ESbE0906E'0 aP^l'35 nod
. OZ'TSL'9T 5 6L'OE6'EZ $ ' L£'60T'IE $ %1759S0Z0E56ST'0 aa+ald not
44'96E'OOT $ 65'EZb'EEt $ ES'0S4'913T $ %Z0E68595T956'O Asuno0 anal'Id
Z8'EZL'69E - -5 'St6TE'LZS $ ,L9'SIS'S89 5. %ZSS£vBL2990S1 a0nl'IS
TT'SBL $ 65'TLT'I $ - 90'956'L $ %E6bOSZLL0L00'0 4..0 aullsf8n9'35
65'£B8'4 $ 95'9L6'9 $ • '£S'690'6 $ 9E19598E016950'0 ..116n9n975
,. - 5 - - $ $ %000000000000'0 Puelau7001
• VI'L $ E9'T $ .. . . - art $ 368855680T0000'0 s8unsen
' ." 9I'ST6189 $ ; " 2Z'OSb'96 $ 6Z'S96'CZT $ 9STET9TBOSE9S9'0 Aluno7 sugar as
L9'TE01bLT" - -$ ,L9'919'842' ," "$ 'L9'TOZEZ£ +$ - %0SS69E£££0InO su4of'15
, TS'L£5'9 $ • • OE'6EE'6 $ 60LbLYT $ %0Z9000Z9ZZ90'0 z8upd5+alulM
LS'Sbi'LT $ , " ZS'969'9Z $ - • eb'LZOY£ S %Z9E066£9Z99I'0 P+olueS
bC'BZB'OI $ E9'691/ST $ •
ZS'0TT'0Z $ %LS08580ET E0T'0 oP^NO
55'644'9 $ -. OS'950'6 $ " ' S9'EE0'LT $ %ST9ET00TLI90'0 po0meuol
09'SLE'B $ , , 9T'696'IT $ 69'955'ST $ %LZBLL9L9L6L0'0 A1eW allel
' £9'E0913 $ - HT'S00'LT $ - -" - 9L'909'ST $ %T6LZ9S9E0080'0 Anaglazze7
80'LES'8 $ EB'S6I'ZI $ : ... . 65'958'ST $ %0E0995S0ET80'0 skui+ds aluowelIV
68'ZI9'95T $ ' ZI'90E'9LL $ 9E'S6T'962 $ %6E8b9T969H051 Alun07 alouma5
LE'T8S'9Z5 $ '68709'6bL ."$ 917'1ZZ'9L6 $ %9b599289TIbT7 a1oui6a5
- B17'996'9T $ - - TI'ZSE'TZ $ - "" 90090LZ $ %09S5BEL9£Z9I'O 001009
' . 09'69B'OS $ . 00169'ZL $ . - " 09'9£9'96 $ %5£96L66Li689'0 elose+e5
' • 6Z'600'ZZ $ - LL'Tb9'TE $ OE'9LB'06 $ %LLZILLTT960Z'0 nod 41,01,1
. 6E'IL9'17 $ Z4'EC9'9 $ 517'SL9'8 $ %958851,695940'0 Aux leogBuol
OT'ESOYOZ $ 6Z•L49'BBZ $ eb'TbZ'SLE $ %TSZE9Z5TE926'T Aluno7 elose+e0
SC'S£Z'LB9. $ 'SE'S9L'186 $ 961,62'9L2'T $' 966LSL58£90508'Z esose+e5
- • 9$'9699 $ TB'b66'9 $ . 52'£60'6 $ %L9ST90LE9900'0 u0711W
' 8L'9I $ " L6'E2 $ - ,. 9T'TE $ %608SBL65T000'O Ae(
T6'905'9 $ EL'Z6Z'6 $ ' b5'080'ZI $ %906LOSLS6T90'0 alaa+g ling
" " . , Z0'STZ'Z9 $ . - . 09-8L8'88 $ - '- — HT'ZSS'STT $ %9TL986£ZSL65'0 Alu^o7 esag ewes
65'OI8'ILT $ 9S'Eb9'S0Z• 5, £9.940'6TE'. . . " ' $ %ETS6TEL9ZTOL'0 ez08 elue5
'. OB'£6 $ ' ' 001,ET $ -. - ' ,OZ•SLT ' $ %£9089£E68000'0 e11e10M
. SB'6E $ " • Z6'95 $ , 00•SL $ %bbET61,6LE000'0 11+ed eu0wud
0E0E6'4 $ , .6Z'E90'L S • .. • LZ'95Y6 $ %9IL49Z556990'O allleled
4L'L6I $ 29'L8Z $ " TT99E $ %684EBb0L0L00'0 oat/aspens
L6'E85 $ - ' SL'bE9 $ ZS'5e01 $ %56L9E9L95500'0 AI171uaasa+7
' - ' EL1895'9E 5 06'68£'69 $ . . . 40'661'99- - $ %Z2L066SZZ6ZE'0 Aluno7 weulnd
£13'86L'66 $ 29'0005'6T - '$ Ob'9ZT'SCT ' $ 9689056TE6859E'0 weulnd
ES'BHT'OL $ b0'SSS'4T 5 . . . - SS'TZ613T - - $ %L809C5££OL60'0 uaneH+aluiM
' WELT $ ' .. t 90'29T $ ' ' " L9'OTZ $ %E600L£090T00'0 AID 1110d
ES'295 $ 9L'ZTe $ - ' 48'5501 $ 46Z00095b19500'0 M+a91^1
' 8L'OTB'E $ , ' . —86'Ebb'S S , LT'LLO'L '$ 961,ET0LTE6Z9E0'O saleM allel
56196'0E $ , • 5ETEZ917 $ 9L'005'LS $ 908998995C8462'0 Pueplie1
ZC'99L $ £0'TBE $ ,. - S£'S69 $ %0£ST EL0b0Z00'0 0.411w0H0901
Sb'98L $ 6b'ELI'I $ - 95'099'L $ %62L096686L00'0 Pa+11V alel
L5'0 $ , ZB'0 $ ' . 901 $ %55LL99S00000'0 z34810H 3sanl1114
L9'9 $ ES'6 $ 6E'2T $ %291155E90000'0 M+ed pue1481H
"'" • _ 06.8E0'0 $ ' ZL'C6T'C $ £0'CSE'6 $ %£98ECC786L90.0 AID aauleH
SO'ST9 $ b9'8L8 $ .- - , EZ'Zb1'I $ %LZ0E09L58500.0 100+dlzo+d
Holly Hill 0.031615805143% Si - 6,165.08 • - $ ' 4,742.37 _ $ 3,319.66 _
Lake Helen 0.004918861482% $. 959.18 .... .$ 737.83 $ 516.48 . _ ..
New Smyrna Beach 0.104065968306%•$ - 20,292.86., ' $ 15,609.90 • $ 10,926.93
Oak Hill 0.004820811087% $ 940.06 • $. 723.12 $ 506.19 '.
Orange City 0.033562287058% $ 6,544.65 . $ 5,034.34 $ 3,524.04 ..
Ormond Beach 0.114644516477% $ 22,355.68 , $ 17,196.68 $ 12,037.67 , '
Pierson 0.002333236251% $ - 454.98 _ • $ 349.99 . $ 244.99 _ _ _
Ponce Inlet 0.023813535748% $ 4,643.64.' $ 3,572.03 $ 2,500.42 .
Port Orange 0.17759650156296 $ 34,631.32' - ' ' $' 26,639.48 $ 18,647.63, ' ' " " -
South Daytona 0.045221205323% $ 8,818.14', ' $ ' 6,783.18 - $ 4,748.23 ' . - ,
Wakulla 0.115129321208% i$• _ . . . . 52,383.84 . '$ _ 40,295.26 $_. . .. '28,206.68_
Wakulla County 0.1149 53 193 6 47% $ 22,415.87 $ 17,242.98 $ 12,070.09
Sopchoppy 0.000107129135% $ 20.89 I $' 16.07 $ 11.25 - __
St.Marks 0.000068998426% $' 13.45 _ _ - $ 10.35 $ 7.2.4
Walton 0.268558216151% 5' - 122,193.99 6' 93,995.38' $ '65,796.76
Walton County 0.224268489581% $ 43,732.36 • - $ 33,640.27 $ 23,548.19
DeFuniak Springs 0.017057137234% $ 3,326.14 - $ 2,558.57 . $ 1,791.00 '
Freeport 0.003290135477% $ 641.58 $ 493.52. $ 345.46
Patton 0.02 3 9 42453 86 0% $ 4,668.78 • - - - . $ 3,591.37 • $ 2,513.96 ' - ,'
Washington 0.120124444109% .$. ._. _ 54,656.62 _ $ 42,04356. $ 29;430:49,
Washington County 0.104908475404% $ 20,457.15 - $ 15,736.27 5. 11,015.39 '
Garyville 0.001401757499% $ 273.34 5 210.26 • $ 147.18
Chipley 0.012550450560% $ 2,447.34 " - - $ 1,882.57 $ 1,317.80 - - •
Ebro 0.000221521263% $ . 43.20 . • $ 33.23 $ 23.26 .
Vernon 0.000361333863% $ 70.46 • $ 54.20 $ 37.94
Wausau 0.000680905521% $' 132.78 $ 102.14 . $ 71.50
100.0096 100.00% $ 19,500,000.00 $ 45,500,000.00 5 15,000,000.00 $ 35,000,000,00 $ 10,500,000.00 $ 24,500,000.00